Dopamine receptors in human peripheral blood lymphocytes: Changes in mRNA expression in opioid addiction

European Journal of Pharmacology

Volumn 615, Issue 1-3, 2009, Pages 218-222

  Goodarzi, Ali ^a,b   Vousooghi, Nasim ^b,c   Sedaghati, Mahsa ^b,c   Mokri, Azarakhsh ^d   Zarrindast, Mohammad Reza ^a,c,d,e  

^a INSTITUTE FOR COGNITIVE SCIENCE STUDIES   (Iran)

^b Sina Cellular and Molecular Research Center   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e INSTITUTE FOR STUDIES IN THEORETICAL PHYSICS AND MATHEMATICS IPM   (Iran)

Author keywords

Dopamine receptor; Human; Lymphocyte; mRNA expression; Opioid

Indexed keywords

DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR; MESSENGER RNA; METHADONE; OPIATE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA EXTRACTION; UPREGULATION;

ADULT; HUMANS; MALE; METHADONE; NARCOTICS; NEUTROPHILS; OPIOID-RELATED DISORDERS; POLYMERASE CHAIN REACTION; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4; RECEPTORS, DOPAMINE D5; RNA, MESSENGER;

EID: 67449126836     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.04.060     Document Type: Article

References (34)

1. American Psychiatric Institute. Diagnostic and Statistical Manual of Mental Disorder. fourth ed. (1994), American Psychiatric Institute, Washington, DC
2. Ammon-Treiber S., and Hollt V. Morphine-induced changes of gene expression in the brain. Addict. Biol. 10 (2005) 81-89
3. 1-like receptors and reward-related incentive learning. Neurosci. Biobehav. Rev. 22 (1998) 335-345
4. Bondy B., Ackenheil M., Birzle W., Elbers R., and Frohler M. Catecholamines and their receptors in blood: evidence for alterations in schizophrenia. Biol. Psychiatry 19 (1984) 1377-1393
5. Carlsson A., Waters N., and Carlsson M.L. Neurotransmitter interactions in schizophrenia-therapeutic implications. Eur. Arch. Psychiatry Clin. Neurosci. 249 Suppl 4 (1999) 37-43
6. 3 receptor expression in blood lymphocytes of smokers is negatively correlated with daily number of smoked cigarettes: a peripheral correlate of dopaminergic alterations in smokers. Nicotine Tob. Res. 6 (2004) 49-54
7. 4 receptor mRNA expression in lymphocytes of long-term abstinent alcohol and heroin addicts. Addiction 99 (2004) 251-257
8. Di Chiara G. A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use. J. Psychopharmacol. 12 (1998) 54-67
9. Duaux E., Krebs M.O., Loo H., and Poirier M.F. Genetic vulnerability to drug abuse. Eur. Psychiatr. 15 (2000) 109-114
10. Gardner E.L., and Ashby Jr. C.R. Heterogeneity of the mesotelencephalic dopamine fibers: physiology and pharmacology. Neurosci. Biobehav. Rev. 24 (2000) 115-118
11. 3 dopamine receptor mRNA in blood lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 625-628
12. Kreek M.J. Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Ann. N.Y. Acad. Sci. 909 (2000) 186-216
13. Kreek M.J., and Vocci F.J. History and current status of opioid maintenance treatments: blending conference session. J. Subst. Abuse Treat. 23 (2002) 93-105
14. Kwak Y.T., Koo M.S., Choi C.H., and Sunwoo I. Change of dopamine receptor mRNA expression in lymphocyte of schizophrenic patients. BMC Med. Genet. 2 (2001) 3
15. 3 receptor expression accompanying behavioral sensitization to nicotine in rats. Synapse 47 (2003) 176-183
16. 4 gene exon III VNTR and heroin abuse in Chinese subjects. Mol. Psychiatry 2 (1997) 413-416
17. 5 receptor and transporter (SLC6A3) polymorphisms on the cue-elicited heroin craving in Chinese. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B (2006) 269-273
18. 2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science 228 (1985) 1115-1117
19. 5 receptor gene (DRD5) show significant association with schizophrenia but not bipolar disorder. Am. J. Med. Genet. 105 (2001) 152-158
20. 3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson's disease. Neurology 46 (1996) 791-795
21. 3 receptor in the morphine-induced rewarding effect and hyperlocomotion. J. Neurosci. 23 (2003) 1006-1012
22. Nestler E.J. Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol. Sci. 25 (2004) 210-218
23. 4 receptor-selective ligand [3H]NGD 94-1. J. Pharmacol. Exp. Ther. 282 (1997) 1020-1027
24. 4 dopamine receptor (DRD4) gene does not predict response to clozapine. Arch. Gen. Psychiatry 51 (1994) 912-917
25. 4 receptors are heterogeneously distributed in the striosomes/matrix compartments of the striatum. J. Neurochem. 80 (2002) 219-229
26. 4 receptors and the risk of cigarette smoking in African-Americans and Caucasians. Cancer Epidemiol. Biomark. Prev. 7 (1998) 453-458
27. 2 receptor antagonists. Eur. J. Pharmacol. 151 (1988) 233-242
28. Shippenberg T.S., Zapata A., and Chefer V.I. Dynorphin and the pathophysiology of drug addiction. Pharmacol. Ther. 116 (2007) 306-321
29. Sibley D.R., Monsma Jr. F.J., and Shen Y. Molecular neurobiology of dopaminergic receptors. Int. Rev. Neurobiol. 35 (1993) 391-415
30. 3 dopamine receptor mRNA in dopaminergic and dopaminoceptive regions of the rat brain in response to morphine. Brain Res. Mol. Brain Res. 111 (2003) 74-83
31. 4 receptor. Neurosci. Lett. 199 (1995) 69-72
32. Vanyukov M.M., Moss H.B., Kaplan B.B., Kirillova G.P., and Tarter R.E. Antisociality, substance dependence, and the DRD5 gene: a preliminary study. Am. J. Med. Genet. 96 (2000) 654-658
33. 3 receptor plays an essential role in alcohol-seeking and relapse. FASEB J. 20 (2006) 2223-2233
34. 3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J. Neural Transm. Gen. Sect. 94 (1993) 11-19